Staffan Josephson

Director/Board Member at

Otre AB

77 year

18 connections

Health Technology

Commercial Services

Finance

Profile

Dr. Staffan Josephson is a Principal at University of Stockholm and Senior Adviser at Investor Growth Capital AB. He is on the Board of Directors at Center for Molecular Medicine & Immunology, Inc. and Otre AB. Dr. Josephson was previously employed as a Director-Research & Development by Pharmacia AB and Senior Investment Manager by Novare Kapital AB. He also served on the board at Affibody AB, Gyros AB, HemoCue AB, and NeuroNova AB.

Staffan Josephson active positions

Companies	Position	Start
University of Stockholm University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Otre AB Otre AB Electronic Production EquipmentElectronic Technology Develops ozone-based sterilization technology	Director/Board Member	-

All active positions of Staffan Josephson

Former positions of Staffan Josephson

Companies	Position	End
Investor Growth Capital AB Investor Growth Capital AB Investment ManagersFinance IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $30 million. They acquire minority interest. IGC Asia targets expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage.	Corporate Officer/Principal	30/12/2009
Novare Kapital AB Novare Kapital AB Personnel ServicesCommercial Services Provided services in the human resources area	Chief Investment Officer	-
Pharmacia AB Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern	Chief Tech/Sci/R&D Officer	-
Center for Molecular Medicine & Immunology, Inc. Center for Molecular Medicine & Immunology, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in commercial physical research	Director/Board Member	-
Gyros AB Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays	Director/Board Member	-

See the detail of Staffan Josephson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Staffan Josephson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Gyros AB Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays	Health Technology
Affibody AB Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment	Health Technology
Investor Growth Capital AB Investor Growth Capital AB Investment ManagersFinance IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $30 million. They acquire minority interest. IGC Asia targets expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage.	Finance
HemoCue AB HemoCue AB Medical SpecialtiesHealth Technology Develops, produces, and markets medical diagnostic products for point of care testing	Health Technology
Pharmacia AB Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern	Health Technology
Novare Kapital AB Novare Kapital AB Personnel ServicesCommercial Services Provided services in the human resources area	Commercial Services
Otre AB Otre AB Electronic Production EquipmentElectronic Technology Develops ozone-based sterilization technology	Electronic Technology
Newron Sweden AB Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders	Health Technology
University of Stockholm University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Center for Molecular Medicine & Immunology, Inc. Center for Molecular Medicine & Immunology, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in commercial physical research	Commercial Services